AbstractMonoclonal antibodies are valuable laboratory reagents and are increasingly being exploited as therapeutics to treat a range of diseases. Selecting new monoclonal antibodies that are validated to work in particular applications, despite the availability of several different techniques, can be resource intensive with uncertain outcomes. To address this, we have developed an approach that enables early screening of hybridoma supernatants generated from an animal immunised with up to five different antigens followed by cloning of the antibody into a single expression plasmid. While this approach relieved the cellular cloning bottleneck and had the desirable ability to screen antibody function prior to cloning, the small volume of hybri...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
AbstractIn recent years, several cell-based screening technologies for the isolation of antibodies w...
AbstractMonoclonal antibodies are valuable laboratory reagents and are increasingly being exploited ...
Abstract Background Although a variety of animals have been used to produce polyclonal antibodies ag...
The demand for monoclonal antibodies (mAbs) in biomedical research is significant, but the current m...
The incapacity to generate a sufficient number of mAbs to conduct large-scale analyses remains one o...
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for researc...
We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-...
Abstract Background Monoclonal antibodies with high affinity and selectivity that work on wholemount...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of ther...
Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of ther...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
AbstractIn recent years, several cell-based screening technologies for the isolation of antibodies w...
AbstractMonoclonal antibodies are valuable laboratory reagents and are increasingly being exploited ...
Abstract Background Although a variety of animals have been used to produce polyclonal antibodies ag...
The demand for monoclonal antibodies (mAbs) in biomedical research is significant, but the current m...
The incapacity to generate a sufficient number of mAbs to conduct large-scale analyses remains one o...
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for researc...
We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-...
Abstract Background Monoclonal antibodies with high affinity and selectivity that work on wholemount...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of ther...
Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of ther...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
The generation of reliable mAb of unique and desired specificities serves as a valuable technology t...
AbstractIn recent years, several cell-based screening technologies for the isolation of antibodies w...